Incidence of atrial fibrillation in a population with impaired glucose tolerance: The contribution of glucose metabolism and other risk factors. A post hoc analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial

Autor: Latini, Roberto, Staszewsky, Lidia, Sun, Jie-Lena, Bethel, M. Angelyn, Disertori, Marcello, Haffner, Steven M., Holman, Rury R., Chang, Futien, Giles, Thomas D., Maggioni, Aldo P., Rutten, Guy E.H.M., Standl, Eberhard, Thomas, Laine, Tognoni, Gianni, Califf, Robert M., McMurray, John J.V.
Zdroj: In American Heart Journal November 2013 166(5):935-940
Databáze: ScienceDirect